With the help of the data and tweets given, can you forecast whether the closing price of $amgn will climb or drop at 2017-06-21? Please state either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-07,-1.1,0.2,-1.2,1.3,1.3,-1.4,-2.8,-3.1,-2.7,-2.0,-1.6
2017-06-08,-0.4,0.3,-0.8,0.6,0.6,-1.2,-2.9,-3.5,-3.2,-2.6,-2.3
2017-06-09,-0.8,1.3,-0.9,0.9,0.9,-1.5,-3.2,-4.0,-3.8,-3.4,-3.0
2017-06-12,0.1,1.4,-1.0,0.5,0.5,-1.4,-3.1,-4.2,-4.1,-3.9,-3.5
2017-06-13,0.0,0.4,-0.4,-0.3,-0.3,-0.5,-2.2,-3.5,-3.7,-3.5,-3.2
2017-06-14,-0.4,0.5,-0.7,0.4,0.4,-0.5,-2.0,-3.4,-4.0,-3.9,-3.5
2017-06-15,0.1,0.5,-1.0,-0.6,-0.6,0.2,-0.9,-2.4,-3.2,-3.2,-2.9
2017-06-16,0.9,1.0,-0.8,-1.0,-1.0,1.1,0.3,-1.1,-2.0,-2.1,-1.9
2017-06-19,-1.2,0.1,-1.5,1.6,1.6,-0.5,-1.0,-2.3,-3.4,-3.5,-3.4
2017-06-20,-0.5,1.4,-0.9,0.7,0.7,-1.0,-1.3,-2.5,-3.7,-4.1,-4.0

2017-06-07: interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|$amgn max pain = 157.50. maturity = 06/09/2017. previous close = 159.53.   |judge puts #amgen's exclusivity
2017-06-08: today's dividends: $1.15 for 1 share of $amgn and $0.39 for 1 share of $msft|$amgn max pain = 157.50. maturity = 06/09/2017. previous close = 161.66.   |rt AT_USER mizuho says lawyer consultant sees 9
2017-06-09: rt AT_USER AT_USER AT_USER $kite $juno $amgn $nvs $bmy $mrk #dcvax will disrupt all. $nwbo $blue $celg $sgen $loxo #pem¡­|rt AT_USER AT_USER AT_USER $kite $juno $amgn $nvs $bmy $mrk #dcvax will disrup
2017-06-10: $amgn (tps 167, 169, 174)  and $agn (above 234 ; tps 240; 243; 255) both looking good to g higher if bios get going this week|healthcare $amgn and $esrx on watchlist on the long side.|  &lt;&lt; jason
2017-06-11: $ibb stong most of the day, closed weak, still watching for roation. select names have been decent $bmy, $amgn $blue |rt AT_USER $amgn is setup for 100% to 200% gains in options. chart plan explains |
2017-06-12: rt AT_USER icymi: biosimilar makers score supreme court win, but questions linger on state laws  $amgn $nvs #¡­|icymi: biosimilar makers score supreme court win, but questions linger on state laws  $a
2017-06-13: $amgn receives nice recommendation for kyprolis|$fbio nice bounce off the 50 day catalyst rich year ahead $tgtx $zsan $kite $juno $clls $cala $cara $amgn $nvs $sny $oncs $srne $loxo $celg|despite abov
2017-06-14: rt AT_USER create a watchlist in enchilada to keep on top of important corporate events $bax $gild $mrk $celg $agn $amgn $jnj |*somebody* is going 2make good $ from a neo-antigen cancer vaccine, imo. 
2017-06-15: $ flows: buying on weakness: among stocks that were down thr, these had the largest net inflows of money: $v $amzn¡­ |rt AT_USER $amgn talk abt muscle memory. long term level of contention |rt AT_USER
2017-06-16: should we be interested in regeneron pharmaceuticals in 2017?  $regn $biib $amgn $sny|$amgn weekly. 20 ma acted as resistance. |amgen: a fairly valued biotech dividend growth play $amgn |rt AT_USER 3 
2017-06-17: abbvie $abbv ltm ebitda multiple trading below majority of peers: $bmy $lly $mrk $pfe $amgn  |{new video} biotech analysis + trade ideas: $ibb $xbi $celg $regn $agn $amgn $nbi --&gt;  |$amgn max pain 
2017-06-18: #amgen, dow, merck among 2017 green chemistry award winners. read more:  $amgn|$amgn oi for maturity 06/23/2017. 162.50 highest put. 172.50 highest call.  |amgen inc. $amgn price target raised to $184
2017-06-19: $amgn looking good with a bull flag on daily, touch of the 10 ema. looking for 174, 179 as next tps. with $ibb looking solid - it shud go|rt AT_USER i have no idea if this will happen but the  $clvs s
2017-06-20: follow #nasdaq 100 traders &amp; track their tweets under one watchlist $amgn $qcom  |like the recap title. the swing biotech list is huge money for members. $clvs $rdus $ptla $ions $amgn |$amgn will 
Answer:
With the help of the data and tweets given, can you forecast whether the closing price of $amgn will climb or drop at 2017-06-21? Please state either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-07,-1.1,0.2,-1.2,1.3,1.3,-1.4,-2.8,-3.1,-2.7,-2.0,-1.6
2017-06-08,-0.4,0.3,-0.8,0.6,0.6,-1.2,-2.9,-3.5,-3.2,-2.6,-2.3
2017-06-09,-0.8,1.3,-0.9,0.9,0.9,-1.5,-3.2,-4.0,-3.8,-3.4,-3.0
2017-06-12,0.1,1.4,-1.0,0.5,0.5,-1.4,-3.1,-4.2,-4.1,-3.9,-3.5
2017-06-13,0.0,0.4,-0.4,-0.3,-0.3,-0.5,-2.2,-3.5,-3.7,-3.5,-3.2
2017-06-14,-0.4,0.5,-0.7,0.4,0.4,-0.5,-2.0,-3.4,-4.0,-3.9,-3.5
2017-06-15,0.1,0.5,-1.0,-0.6,-0.6,0.2,-0.9,-2.4,-3.2,-3.2,-2.9
2017-06-16,0.9,1.0,-0.8,-1.0,-1.0,1.1,0.3,-1.1,-2.0,-2.1,-1.9
2017-06-19,-1.2,0.1,-1.5,1.6,1.6,-0.5,-1.0,-2.3,-3.4,-3.5,-3.4
2017-06-20,-0.5,1.4,-0.9,0.7,0.7,-1.0,-1.3,-2.5,-3.7,-4.1,-4.0

2017-06-07: interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|$amgn max pain = 157.50. maturity = 06/09/2017. previous close = 159.53.   |judge puts #amgen's exclusivity
2017-06-08: today's dividends: $1.15 for 1 share of $amgn and $0.39 for 1 share of $msft|$amgn max pain = 157.50. maturity = 06/09/2017. previous close = 161.66.   |rt AT_USER mizuho says lawyer consultant sees 9
2017-06-09: rt AT_USER AT_USER AT_USER $kite $juno $amgn $nvs $bmy $mrk #dcvax will disrupt all. $nwbo $blue $celg $sgen $loxo #pem¡­|rt AT_USER AT_USER AT_USER $kite $juno $amgn $nvs $bmy $mrk #dcvax will disrup
2017-06-10: $amgn (tps 167, 169, 174)  and $agn (above 234 ; tps 240; 243; 255) both looking good to g higher if bios get going this week|healthcare $amgn and $esrx on watchlist on the long side.|  &lt;&lt; jason
2017-06-11: $ibb stong most of the day, closed weak, still watching for roation. select names have been decent $bmy, $amgn $blue |rt AT_USER $amgn is setup for 100% to 200% gains in options. chart plan explains |
2017-06-12: rt AT_USER icymi: biosimilar makers score supreme court win, but questions linger on state laws  $amgn $nvs #¡­|icymi: biosimilar makers score supreme court win, but questions linger on state laws  $a
2017-06-13: $amgn receives nice recommendation for kyprolis|$fbio nice bounce off the 50 day catalyst rich year ahead $tgtx $zsan $kite $juno $clls $cala $cara $amgn $nvs $sny $oncs $srne $loxo $celg|despite abov
2017-06-14: rt AT_USER create a watchlist in enchilada to keep on top of important corporate events $bax $gild $mrk $celg $agn $amgn $jnj |*somebody* is going 2make good $ from a neo-antigen cancer vaccine, imo. 
2017-06-15: $ flows: buying on weakness: among stocks that were down thr, these had the largest net inflows of money: $v $amzn¡­ |rt AT_USER $amgn talk abt muscle memory. long term level of contention |rt AT_USER
2017-06-16: should we be interested in regeneron pharmaceuticals in 2017?  $regn $biib $amgn $sny|$amgn weekly. 20 ma acted as resistance. |amgen: a fairly valued biotech dividend growth play $amgn |rt AT_USER 3 
2017-06-17: abbvie $abbv ltm ebitda multiple trading below majority of peers: $bmy $lly $mrk $pfe $amgn  |{new video} biotech analysis + trade ideas: $ibb $xbi $celg $regn $agn $amgn $nbi --&gt;  |$amgn max pain 
2017-06-18: #amgen, dow, merck among 2017 green chemistry award winners. read more:  $amgn|$amgn oi for maturity 06/23/2017. 162.50 highest put. 172.50 highest call.  |amgen inc. $amgn price target raised to $184
2017-06-19: $amgn looking good with a bull flag on daily, touch of the 10 ema. looking for 174, 179 as next tps. with $ibb looking solid - it shud go|rt AT_USER i have no idea if this will happen but the  $clvs s
2017-06-20: follow #nasdaq 100 traders &amp; track their tweets under one watchlist $amgn $qcom  |like the recap title. the swing biotech list is huge money for members. $clvs $rdus $ptla $ions $amgn |$amgn will 
Answer:+Rise